Pfizer: News
Norway raises COVID-19 vaccine concerns for elderly after 29 deaths
Norway has expressed concern over the safety of the COVID-19 vaccine developed by Pfizer and BioNTech among older populations as 29 people died after receiving the shot.
Pfizer study suggests vaccine works against coronavirus variant
New research suggests that Pfizer's COVID-19 vaccine can protect against a mutation found in two contagious variants of the coronavirus that erupted in Britain and South Africa.
Full lockdown imposed in England as coronavirus cases surge
England's 56 million people were ordered to stay at home by Prime Minister Boris Johnson on Monday, as the United Kingdom struggles to contain a new variant of coronavirus.
India could approve coronavirus vaccine soon, key meeting today
After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.
WHO approves Pfizer-BioNTech's coronavirus vaccine for emergency use
The World Health Organization (WHO) on Thursday granted "emergency validation" to the coronavirus vaccine developed by Pfizer and BioNTech, making it the first vaccine to be given such an approval by the United Nations body.
How Delhi Airport plans to help in coronavirus vaccine distribution
India is gearing up to distribute vaccines to crores of people but the task will be replete with many problems, including ensuring last-mile deliveries and storing doses at a safe temperature.
Can prepare vaccine against mutated virus in 6 weeks: BioNTech
Ugur Sahin, the co-founder and CEO of the German drugmaker BioNTech, displayed confidence that their COVID-19 vaccine can work against the new strain of the coronavirus.
US President-elect Joe Biden receives coronavirus vaccine on live television
On Monday, United States President-elect Joe Biden received the first shot of the coronavirus vaccine on live television, in an obvious bid to junk myths about the doses and tell Americans that it is safe to get inoculated.
Coronavirus: Myths about the COVID-19 vaccine busted
As vaccines for COVID-19 have started being rolled out in parts of the world, certain myths have been propagated questioning their safety and efficacy.
Coronavirus vaccine could turn you into 'crocodile': Brazil's President
Jair Bolsonaro, the President of Brazil, who tested positive for coronavirus twice, has given a bizarre statement about vaccines. He suggested that the one developed by Pfizer and BioNTech could turn people into "crocodiles," and that the company won't take any responsibility.
United States has approved Moderna's COVID-19 vaccine, says Trump
Moderna's COVID-19 vaccine has been approved in the United States, outgoing President Donald Trump announced ahead of the nation's drug regulator.
FDA advisors recommend Emergency Use Authorization of Moderna vaccine
The US Food and Drug Administration's advisory panel, comprising external experts, has given an emergency use approval to Moderna's COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorization in less than a week.
French President Emmanuel Macron tests positive for coronavirus
French President Emmanuel Macron has tested positive for coronavirus, joining the long list of notable international personalities to have contracted the disease, that originated in China late last year.
US angling to secure more of Pfizer's coronavirus vaccine
U.S. officials have said that they are actively negotiating for additional purchases of Pfizer's coronavirus vaccine after they missed the chance to lock in a contract this summer since it was still unclear how well the shots would work.
Moderna vaccine has 'no specific safety concerns,' says US regulator
Moderna's COVID-19 vaccine has been found safe and effective, the United States Food and Drug Administration said in a report on Tuesday.
US, where over 300,000 died of coronavirus, starts vaccination drive
The biggest ever vaccination drive in the United States started on Monday, as health workers were given the first doses of the coronavirus vaccine.
US clears Pfizer coronavirus vaccine, first shot in 24 hours
The Food and Drug Administration (FDA) on Friday authorized Pfizer-BioNTech's COVID-19 vaccine, clearing the way for its mass rollout across the United States.
Pfizer vaccine: UK issues allergy warning after two adverse reactions
British medicine regulator on Wednesday advised people with a history of significant allergic reactions against getting the COVID-19 vaccine developed by Pfizer and BioNTech.
COVID-19 vaccine: 90-year-old woman receives first Pfizer shot in UK
A 90-year-old woman in the United Kingdom has become the world's first person to receive the COVID-19 vaccine developed by Pfizer and BioNTech outside of clinical trials.
Serum seeks emergency use approval for Oxford's coronavirus vaccine
Pune-based Serum Institute of India (SII) has sought emergency use authorization from Drugs Controller General of India (DCGI) for the coronavirus vaccine, which is developed by the University of Oxford and the British-pharma giant AstraZeneca, multiple reports said.
Pfizer seeks emergency approval for COVID-19 vaccine in India
United States-based pharmaceutical giant Pfizer has sought emergency approval for its COVID-19 vaccine from India's drug regulator.
Indians willing to travel to UK to get coronavirus vaccine
After the British government approved the coronavirus vaccine developed by US-based Pfizer and Germany's BioNTech, a number of Indians contacted travel agents, showing a willingness to travel to the country to get inoculated.
Putin orders Russian authorities to start mass COVID-19 vaccinations
Russian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.
UK approves Pfizer-BioNTech's COVID-19 vaccine; first doses expected next week
The United Kingdom on Wednesday gave emergency approval to Pfizer and BioNTech's COVID-19 vaccine, becoming the first Western country to allow mass immunization against the viral disease.
Will being exposed to low quantities of coronavirus generate immunity?
Developing immunity against COVID-19 through repeated low-dose exposures is possible, however, it is not likely, Dr. James Hamblin said while responding to a query in his 'Paging Dr. Hamblin' column in The Atlantic.
Deliveries of Pfizer-BioNTech's coronavirus vaccine could start before Christmas
The world, battered by coronavirus pandemic, would get relief as early as Christmas, as the vaccine developed by Pfizer and BioNTech could be out by then, an official from the German company said.
Pfizer's COVID-19 vaccine '95% effective'; to seek emergency US authorization
Pharmaceutical giant Pfizer and German drugmaker BioNTech on Wednesday said their COVID-19 vaccine has been found 95% effective in final trials.
Days after upsetting results, Trump comes close to conceding defeat
Refusing to concede defeat for days now, US President Donald Trump came closest ever to accepting his fate on Friday, by blurting that "time will tell" if he remains at the helm of the most powerful nation or not.
US planning Pfizer's coronavirus vaccine distribution as early as December
The United States could begin inoculating its citizens with Pfizer's coronavirus vaccine as early as December, provided the drugmaker submits data from its trial to health regulators, Health Secretary Alex Azar said on Tuesday.
Sensex, Nifty hit record highs as markets welcome vaccine news
Domestic stock markets hit fresh record highs on Tuesday as drugmakers Pfizer and BioNTech announced that their COVID-19 vaccine candidate was over 90% effective.
Meet the husband-wife duo behind Pfizer-BioNTech's COVID-19 vaccine
United States pharmaceutical giant Pfizer and German biotech firm BioNTech had on Monday announced that their COVID-19 vaccine candidate is over 90% effective based on initial data from a large study.
Trump says Pfizer withheld announcement on COVID-19 vaccine before election
United States President Donald Trump has accused pharmaceutical giant Pfizer and the US Food and Drug Administration of delaying the announcement on a COVID-19 vaccine until after the 2020 Presidential election.
Pfizer, BioNTech say their COVID-19 vaccine is over 90% effective
United States pharmaceutical giant Pfizer and German biotech firm BioNTech have said their COVID-19 vaccine is over 90% effective, according to initial data from a large study.
Coronavirus vaccine in 2020? US drugmaker Pfizer isn't saying no!
Even as experts worldwide have said that an effective coronavirus vaccine won't be out before 2021, American pharma giant Pfizer is hoping to deliver one this year itself, igniting hopes globally.
Johnson & Johnson's COVID-19 vaccine goes into final human trials
In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.
COVID-19 vaccine developers to pledge against rolling out shots prematurely
In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.
#VaccineTracker: Early COVID-19 vaccine results expected by September 15
As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.
Pfizer's COVID-19 vaccine shows promise in human trials: Details here
The COVID-19 candidate vaccine jointly developed by American pharma giant Pfizer and German biotech company BioNTech has shown promise in early human trials.
As coronavirus pandemic surges, some vaccine makers expect to profit
Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.
As Pfizer's Viagra patent ends, Indian firms prepare for dominance
Viagra, the global leader in treating impotence in men, might soon be dethroned, as pharmaceutical giant Pfizer loses its patent for the drug in the US in 2020.